Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion

Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion

Purpose To evaluate the efficacy and safety of sequential therapy with ranibizumab followed by dexamethasone intravitreal implant compared with dexamethasone monotherapy for macular oedema (MO) secondary to retinal vein occlusion (RVO). Methods In this retrospective interventional study, the medical...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Iu, L, Zhao, P, Yeung, I, Fung, N, Lee, J, Wong, R, Chong, V, Wong, I
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	BMJ Publishing Group 2014

Eitemau Tebyg

Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
gan: Xuemei Liang, et al.
Cyhoeddwyd: (2022-09-01)

Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
gan: Ayşe Ergin, et al.
Cyhoeddwyd: (2022-12-01)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
gan: Alper Halil Bayat, et al.
Cyhoeddwyd: (2019-12-01)

Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
gan: Frederic Matonti, et al.
Cyhoeddwyd: (2012-10-01)

Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
gan: Tranos P, et al.
Cyhoeddwyd: (2024-11-01)

Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema
gan: Fernando de Andrés-Nogales, et al.
Cyhoeddwyd: (2018-11-01)

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
gan: Antoine Herbaut, et al.
Cyhoeddwyd: (2017-01-01)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
gan: Jia-Kang Wang, et al.
Cyhoeddwyd: (2021-01-01)

Macular Electrophysiology After Intravitreal Dexamethasone Implant in Patients with Branch Retinal Vein Occlusion
gan: Muhammed Nurullah Bulut, et al.
Cyhoeddwyd: (2020-03-01)

Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
gan: Mohamed Loutfi, et al.
Cyhoeddwyd: (2014-01-01)

Comparison of Ranibizumab alone versus Ranibizumab with Targeted Retinal Laser for Branch Retinal Vein Occlusion with Macular Oedema.
gan: Mohamed Abdelmoneem, et al.
Cyhoeddwyd: (2022-10-01)

Intravitreal Injection of Conbercept Combined with Dexamethasone for Macular Edema Following Central Retinal Vein Occlusion
gan: Wu P, et al.
Cyhoeddwyd: (2024-06-01)

Comparison of changes in number of hyperreflective dots after intravitreal ranibizumab or dexamethasone implant in patients with branch retinal vein occlusion
gan: Aylin Karalezli, et al.
Cyhoeddwyd: (2023-05-01)

Long-term Results of Ranibizumab, Dexamethasone Implant, and Triamcinolone in Macular Edema due to Branch Retinal Vein Occlusion
gan: Nevin Hande Dikel, et al.
Cyhoeddwyd: (2019-12-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
gan: Santosh K Mahapatra, et al.
Cyhoeddwyd: (2024-01-01)

Intravitreal Injection of Dexamethasone Implant and Ranibizumab in Cystoid Macular Edema in the Course of Irvine-Gass Syndrome
gan: Vito Fenicia, et al.
Cyhoeddwyd: (2014-08-01)

The Application of Structural Retinal Biomarkers to Evaluate the Effect of Intravitreal Ranibizumab and Dexamethasone Intravitreal Implant on Treatment of Diabetic Macular Edema
gan: Ida Ceravolo, et al.
Cyhoeddwyd: (2020-06-01)

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.
gan: Ahmed Abdel-Hay, et al.
Cyhoeddwyd: (2018-01-01)

INTRAVITREAL IMPLANT OF DEXAMETHASONE IN THE TREATMENT OF RETINAL VEIN OCCLUSION: EFFICACY AND SAFETY
gan: A. E. Yavorskiy, et al.
Cyhoeddwyd: (2015-10-01)

Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.
gan: Chen, S, et al.
Cyhoeddwyd: (2004)

Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
gan: Alex Yuan, et al.
Cyhoeddwyd: (2014-02-01)

Combined dexamethasone intravitreal implant (Ozurdex) and macular grid laser versus combined intravitreal bevacizumab and macular grid laser in branch retinal vein occlusion with macular edema
gan: Abdelrahman G Salman
Cyhoeddwyd: (2015-01-01)

Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study
gan: Paul Mitchell, et al.
Cyhoeddwyd: (2023-06-01)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
gan: Laine I, et al.
Cyhoeddwyd: (2017-11-01)

Impact of Intravitreal Dexamethasone Implant on Vessel Diameters in Patients with Retinal Vein Occlusion
gan: Busra Yilmaz Tugan, et al.
Cyhoeddwyd: (2019-01-01)

Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant
gan: Alfredo Niro, et al.
Cyhoeddwyd: (2018-01-01)

Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
gan: Taro Otawa, et al.
Cyhoeddwyd: (2022-06-01)

Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients
gan: Hatice Ayhan Güler, et al.
Cyhoeddwyd: (2018-09-01)

Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa
gan: Amelie Pielen, et al.
Cyhoeddwyd: (2017-01-01)

Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion
gan: Carmen Antía Rodríguez-Fernández, et al.
Cyhoeddwyd: (2022-01-01)

Comment on “Intravitreal dexamethasone implants for diabetic macular edema”
gan: Dan Călugăru, et al.
Cyhoeddwyd: (2018-12-01)

Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion
gan: Marcel N. Menke, et al.
Cyhoeddwyd: (2016-01-01)

Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
gan: Seong Joon Ahn, et al.
Cyhoeddwyd: (2018-12-01)

Changes of central macular thickness post intravitreal ranibizumab and its associated factors among diabetic macular oedema patients
gan: Tahir, Nursyafiqah Md
Cyhoeddwyd: (2020)

Morphological and Functional Outcomes after Intravitreal Dexamethasone Injection for Macular Edema in Patients with Central Vein Occlusion at 48-Week Follow-Up
gan: Cristina Nicula, et al.
Cyhoeddwyd: (2020-01-01)

The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario
gan: Mert Simsek, et al.
Cyhoeddwyd: (2018-01-01)

Efficacy and Safety in Retinal Vein Occlusion Treated with at Least Three Consecutive Intravitreal Dexamethasone Implants
gan: Julia Proença Pina, et al.
Cyhoeddwyd: (2016-01-01)

Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema
gan: Kanako Yasuda, et al.
Cyhoeddwyd: (2023-05-01)

The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials
gan: Li Xiaodong, et al.
Cyhoeddwyd: (2022-01-01)

A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.
gan: Sivaprasad, S, et al.
Cyhoeddwyd: (2011)